Christina Charles-Schoeman, MD, MS

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Abbvie
    Topic:
    Rheumatoid Arthritis
    Date added:
    07/15/2026
    Date updated:
    07/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Sana Biotechnology
    Topic:
    Rheumatoid arthritis
    Date added:
    07/15/2026
    Date updated:
    07/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Octapharma
    Topic:
    Myositis
    Date added:
    07/15/2026
    Date updated:
    07/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Immunovant
    Topic:
    Rheumatoid arthritis
    Date added:
    07/15/2026
    Date updated:
    07/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Pfizer
    Topic:
    Myositis and JAK inhibitors
    Date added:
    07/15/2026
    Date updated:
    07/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Psoriatic arthritis
    Date added:
    07/15/2026
    Date updated:
    07/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Boehringer Ingelheim
    Topic:
    Myositis and Lung Disease
    Date added:
    07/15/2026
    Date updated:
    07/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Priovant
    Topic:
    Myositis
    Date added:
    07/15/2026
    Date updated:
    07/15/2026
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Argenx
    Topic:
    Myositis
    Date added:
    07/15/2026
    Date updated:
    07/15/2026
Return to Association of Women in Rheumatology 2026 Annual Conference